Peter Lo

816 total citations
11 papers, 599 citations indexed

About

Peter Lo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Peter Lo has authored 11 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Surgery. Recurrent topics in Peter Lo's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (3 papers). Peter Lo is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (3 papers). Peter Lo collaborates with scholars based in United States, Pakistan and Hong Kong. Peter Lo's co-authors include Bruce E. Johnson, David M. Jackman, Geoffrey R. Oxnard, Pasi A. Jänne, Mizuki Nishino, Suzanne E. Dahlberg, Mohit Butaney, Neal I. Lindeman, Adnan Majid and Steffi Sunny and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Peter Lo

9 papers receiving 594 citations

Peers

Countries citing papers authored by Peter Lo

Since Specialization

Citations

This map shows the geographic impact of Peter Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lo more than expected).

Fields of papers citing papers by Peter Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lo. The network helps show where Peter Lo may publish in the future.

Co-authorship network of co-authors of Peter Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lo. A scholar is included among the top collaborators of Peter Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lo. Peter Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Colorectal Cancer Screening Challenges in the Recent Afghan Refugee Population: A Comprehensive Review Article 2022 ·Cureus ·(unknown), (unknown), (unknown), Siamak M. Seraj, Jaffar M. Khan, (unknown), (unknown), Peter Lo, (unknown), (unknown), Asad Ullah, (unknown)	0
2	SU‐F‐R‐39: Effects of Radiation Dose Reduction On Renal Cell Carcinoma Discrimination Using Multi‐Phasic CT Imaging 2016 ·Medical Physics ·(unknown), S. Young, Peter Lo, (unknown), (unknown), Matthew S. Brown, (unknown), Heidi Coy, (unknown), (unknown)	1
3	Transparent antifouling material for improved operative field visibility in endoscopy 2016 ·Proceedings of the National Academy of Sciences ·Steffi Sunny, George Cheng, Dan Daniel, Peter Lo, Sebastian Ochoa, Caitlin Howell, Nicolas Vogel, Adnan Majid, Joanna Aizenberg	118
4	The Accuracy of Computed Tomography to Predict Completeness of Pulmonary Fissures. A Prospective Study 2015 ·Annals of the American Thoracic Society ·Michael S. Kent, Carole A. Ridge, David D. Odell, Peter Lo, Richard I. Whyte, Sidhu P. Gangadharan	9
5	Delay of treatment change after objective progression on first‐line erlotinib in epidermal growth factor receptor‐mutant lung cancer 2015 ·Cancer ·Peter Lo, Suzanne E. Dahlberg, Mizuki Nishino, Bruce E. Johnson, Lecia V. Sequist, David M. Jackman, Pasi A. Jänne, Geoffrey R. Oxnard	38
6	Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer 2014 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Angel M. Cronin, David Kozono, Geoffrey R. Oxnard, Raymond H. Mak, David M. Jackman, Peter Lo, Elizabeth H. Baldini, Bruce E. Johnson, Aileen B. Chen	110
7	Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions 2013 ·Journal of Thoracic Oncology ·Geoffrey R. Oxnard, Peter Lo, Mizuki Nishino, Suzanne E. Dahlberg, Neal I. Lindeman, Mohit Butaney, David M. Jackman, Bruce E. Johnson, Pasi A. Jänne	261
8	The spectrum of genomic alterations in young adult non-small cell lung cancer (NSCLC). 2013 ·Journal of Clinical Oncology ·Geoffrey R. Oxnard, Jennifer Heng, Stacy L. Mach, Peter Lo, Mohit Butaney, David M. Jackman, Pasi A. Jänne	0
9	Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe 2013 ·Annals of Hepatology ·Grace Lai–Hung Wong, Julien Vergniol, Peter Lo, Vincent Wai‐Sun Wong, Juliette Foucher, Brigitte Le Bail, Paul Cheung‐Lung Choi, Faïza Chermak, Kwong-Sak Leung, Wassil Merrouche, Henry Lik‐Yuen Chan, Victor de Lédinghen	29
10	Factors Associated With Survival in Patients With Oligometastatic Non-Small Cell Lung Cancer (NSCLC) 2013 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), A. Cronin, David Kozono, Geoffrey R. Oxnard, Raymond H. Mak, D. M. Jackman, Peter Lo, (unknown), Bruce E. Johnson, (unknown)	1
11	Delay of chemotherapy through use of post-progression erlotinib in patients with EGFR-mutant lung cancer. 2012 ·Journal of Clinical Oncology ·Geoffrey R. Oxnard, Peter Lo, David M. Jackman, Mohit Butaney, Stéphanie Héon, Bruce E. Johnson, Lecia V. Sequist, Pasi A. Jänne	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact